Wockhardt

[dass]

Profile
Introduction | Business | Partnership | Location |
Introduction

Wockhardt is a Mumbai-based global, pharmaceutical and biotechnology company. The company has an annual turnover of over US$ 300 million. Half of its revenue comes from Europe and the United States. It employs 4,000 people in India, UK, Germany, USA, and in emerging markets. The company's stock is listed on BSE and NSE and the Luxembourg Stock Exchange in Europe.
Business

Wockhardt's manufacturing facilities in India and the UK have the approval of major regulatory bodies, including US FDA and UK's MHRA, with capabilities for both finished dosage formulations and APIs. The output includes Steriles (Injectables), Biopharmaceuticals, Orals (Tablets & Liquids) and Topicals (Creams & Ointments).

top
Partnership

Wockhardt has entered into manufacturing alliances with leading pharmaceutical and biotechnology majors like Astra Zeneca, Lab Aguettant, Aventis, Amylin, Schering-Plough, Eisai and Cell Therapeutics.
Location

The company, with its headquarters in India, has 10 manufacturing plants in India and UK; subsidiaries in US, UK and Brazil; majority-owned companies in South Africa and Mexico and marketing offices in Africa, Russia, Central and South East Asia.